Group One Trading
TFFP

Group One Trading’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Group One Trading’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,364
Closed -$138K – 8272
2022
Q3 		$138K Sell
1,364
-728
-35% -$98.5K ﹤0.01% 4481
2022
Q2 		$296K Sell
2,092
-480
-19% -$67K ﹤0.01% 3918
2022
Q1 		$406K Buy
2,572
+40
+2% +$6.46K ﹤0.01% 4044
2021
Q4 		$561K Buy
2,532
+1,804
+248% +$349K ﹤0.01% 3999
2021
Q3 		$141K Buy
728
+392
+117% +$83.2K ﹤0.01% 5543
2021
Q2 		$81K Buy
336
+32
+11% +$8.78K ﹤0.01% 6168
2021
Q1 		$103K Buy
304
+232
+322% +$94.3K ﹤0.01% 5638
2020
Q4 		$26K Buy
72
+20
+38% +$7.7K ﹤0.01% 5380
2020
Q3 		$24K Buy
+52
New +$14.7K ﹤0.01% 5056

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Group One Trading's TFFP Position: Q1 2024 in Review

Group One Trading sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2024, closing a stake of 39 shares — an estimated $274 sold.

Group One Trading first reported a position in TFFP in Q3 2020 and held it in 7 quarters. The position peaked at $414K in Q4 2021. 19 funds tracked by Wall St. Rank hold TFFP as of Q1 2024.

  • Group One Trading reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 39 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $274.
  • Group One Trading first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
  • Group One Trading's TFF Pharmaceuticals, Inc. Common Stock position peaked at $414K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.